BCDA
Price
$2.06
Change
+$0.02 (+0.98%)
Updated
Sep 5 closing price
Capitalization
11.95M
CDTX
Price
$63.17
Change
-$1.76 (-2.71%)
Updated
Sep 5 closing price
Capitalization
1.6B
Interact to see
Advertisement

BCDA vs CDTX

Header iconBCDA vs CDTX Comparison
Open Charts BCDA vs CDTXBanner chart's image
BioCardia
Price$2.06
Change+$0.02 (+0.98%)
Volume$28.38K
Capitalization11.95M
Cidara Therapeutics
Price$63.17
Change-$1.76 (-2.71%)
Volume$424.6K
Capitalization1.6B
BCDA vs CDTX Comparison Chart in %
Loading...
BCDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCDA vs. CDTX commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCDA is a StrongBuy and CDTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (BCDA: $2.06 vs. CDTX: $63.17)
Brand notoriety: BCDA and CDTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCDA: 7% vs. CDTX: 78%
Market capitalization -- BCDA: $11.95M vs. CDTX: $1.6B
BCDA [@Biotechnology] is valued at $11.95M. CDTX’s [@Biotechnology] market capitalization is $1.6B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCDA’s FA Score shows that 0 FA rating(s) are green whileCDTX’s FA Score has 0 green FA rating(s).

  • BCDA’s FA Score: 0 green, 5 red.
  • CDTX’s FA Score: 0 green, 5 red.
According to our system of comparison, CDTX is a better buy in the long-term than BCDA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCDA’s TA Score shows that 5 TA indicator(s) are bullish while CDTX’s TA Score has 2 bullish TA indicator(s).

  • BCDA’s TA Score: 5 bullish, 4 bearish.
  • CDTX’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, BCDA is a better buy in the short-term than CDTX.

Price Growth

BCDA (@Biotechnology) experienced а +4.20% price change this week, while CDTX (@Biotechnology) price change was -3.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CDTX($1.6B) has a higher market cap than BCDA($12M). CDTX YTD gains are higher at: 135.007 vs. BCDA (-5.505). BCDA has higher annual earnings (EBITDA): -8.81M vs. CDTX (-208.92M). CDTX has more cash in the bank: 511M vs. BCDA (980K). BCDA has less debt than CDTX: BCDA (745K) vs CDTX (2.33M). BCDA (0) and CDTX (0) have equivalent revenues.
BCDACDTXBCDA / CDTX
Capitalization12M1.6B1%
EBITDA-8.81M-208.92M4%
Gain YTD-5.505135.007-4%
P/E RatioN/AN/A-
Revenue00-
Total Cash980K511M0%
Total Debt745K2.33M32%
FUNDAMENTALS RATINGS
BCDA vs CDTX: Fundamental Ratings
BCDA
CDTX
OUTLOOK RATING
1..100
1075
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
86
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
6134
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CDTX's Valuation (86) in the Biotechnology industry is in the same range as BCDA (88) in the null industry. This means that CDTX’s stock grew similarly to BCDA’s over the last 12 months.

CDTX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as BCDA (100) in the null industry. This means that CDTX’s stock grew similarly to BCDA’s over the last 12 months.

CDTX's SMR Rating (97) in the Biotechnology industry is in the same range as BCDA (100) in the null industry. This means that CDTX’s stock grew similarly to BCDA’s over the last 12 months.

CDTX's Price Growth Rating (34) in the Biotechnology industry is in the same range as BCDA (61) in the null industry. This means that CDTX’s stock grew similarly to BCDA’s over the last 12 months.

CDTX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as BCDA (100) in the null industry. This means that CDTX’s stock grew similarly to BCDA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BCDACDTX
RSI
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
78%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 9 days ago
78%
Bullish Trend 17 days ago
85%
Declines
ODDS (%)
Bearish Trend 17 days ago
89%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
BCDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
POVSX31.630.13
+0.41%
Putnam International Equity A
JMVZX33.71N/A
N/A
JPMorgan Mid Cap Value R2
PSCRX16.01N/A
N/A
Putnam Small Cap Value R
MGQAX18.00N/A
N/A
Morgan Stanley Inst Global Stars A
FGEMX135.58N/A
N/A
Fidelity Advisor Communication ServicesM

BCDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCDA has been closely correlated with RNAC. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if BCDA jumps, then RNAC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCDA
1D Price
Change %
BCDA100%
+0.98%
RNAC - BCDA
85%
Closely correlated
+6.40%
CDTX - BCDA
85%
Closely correlated
-2.71%
AGEN - BCDA
85%
Closely correlated
+0.93%
NBY - BCDA
84%
Closely correlated
-11.61%
TAOX - BCDA
84%
Closely correlated
+6.91%
More

CDTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CDTX has been closely correlated with NBY. These tickers have moved in lockstep 93% of the time. This A.I.-generated data suggests there is a high statistical probability that if CDTX jumps, then NBY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDTX
1D Price
Change %
CDTX100%
-2.71%
NBY - CDTX
93%
Closely correlated
-11.61%
NCNA - CDTX
93%
Closely correlated
+0.35%
TAOX - CDTX
93%
Closely correlated
+6.91%
BPTSY - CDTX
92%
Closely correlated
N/A
KPRX - CDTX
90%
Closely correlated
-1.83%
More